HAWTHORNE, N.Y.–(BUSINESS WIRE)–Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter ended June 30, 2020, after the close of market on Wednesday, July 29, 2020.
The release will be accessible on Taro’s website at www.taro.com.
About Taro
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.
Contacts
Daphne Huang
VP, CFO
(914) 345-9001
Daphne.Huang@Taro.com
William J. Coote
AVP, Business Finance, Treasurer and Investor Relations
(914) 345-9001
William.Coote@Taro.com
Hong Kong and Macau Organisations Honoured for Outstanding Achievements ESG-led Business for a Sustainable FutureHONG…
HONG KONG SAR - Media OutReach Newswire -19 December 2025 - HKAccidentLawyers.com and the HKCivilClaim.com…
HANOI, VIETNAM - Media OutReach Newswire – 19 December 2025 - In celebration of the…
Get ready, Malaysia! Plug & Play 5g advanced home WiFi with premium streaming has now…
JAKARTA, INDONESIA - Media OutReach Newswire – 19 December 2025 – At the Kumparan Awards:…
SINGAPORE - Media OutReach Newswire - 19 December 2025 – As hiring expectations continue to…